Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -281.87 Million SAR | -103.45% |
| 2022 | -138.54 Million SAR | -25.2% |
| 2021 | -110.66 Million SAR | 19.98% |
| 2020 | -138.3 Million SAR | 4.17% |
| 2019 | -144.32 Million SAR | -43.7% |
| 2018 | -100.43 Million SAR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -208.31 Million SAR | 26.1% |
| 2024 Q2 | -154.12 Million SAR | 26.01% |
| 2023 FY | -281.87 Million SAR | -103.45% |
| 2023 Q3 | -90.81 Million SAR | 45.91% |
| 2023 Q1 | -91.4 Million SAR | 34.03% |
| 2023 Q4 | -281.87 Million SAR | -210.38% |
| 2023 Q2 | -167.89 Million SAR | -83.69% |
| 2022 Q1 | 151.99 Million SAR | 237.04% |
| 2022 Q4 | -138.54 Million SAR | 0.0% |
| 2022 FY | -138.54 Million SAR | -25.2% |
| 2022 Q2 | -97.02 Million SAR | -163.84% |
| 2021 Q1 | 256.08 Million SAR | 0.0% |
| 2021 FY | -110.66 Million SAR | 19.98% |
| 2021 Q4 | -110.91 Million SAR | 0.0% |
| 2021 Q3 | -110.91 Million SAR | 0.0% |
| 2020 FY | -138.3 Million SAR | 4.17% |
| 2019 FY | -144.32 Million SAR | -43.7% |
| 2018 FY | -100.43 Million SAR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 940 Million SAR | 129.987% |